MEDICLINIC INTERNATIONAL LIMITED - Disclosure Of Changes in Beneficial Interest

Disclosure Of Changes in Beneficial Interest

Mediclinic International Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
Share Code: MDC
(“Mediclinic” or “the company”)

DISCLOSURE OF CHANGES IN BENEFICIAL INTEREST

In accordance with the JSE Limited Listings Requirements and
section 122(1) of the Companies Act, 71 of 2008, as amended,
shareholders are advised that The International Hospitals Network
Partnership (“IHN”), an associate of Trilantic Capital Partners,
informed the company on 1 October 2012 that it disposed of
Mediclinic ordinary shares reducing its interest from 6.01% to
4.81% in the issued shares of Mediclinic.

Stellenbosch
2 October 2012

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com

Sponsor
RAND MERCHANT BANK (a division of FirstRand Bank Limited)

Date: 02/10/2012 01:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.